BioNTech SE Finance Costs
BioNTech SE (BNTX) reported Finance Costs of EUR 69.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2026-03-10
| Period end | Finance Costs 12 month | Finance Costs 12 month as first filed |
|---|---|---|
| 2025-12-31 | 69.80M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 27.40M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 23.90M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 18.90M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 305.10M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 65.00M EUR 20-F · filed 2023-03-27 | 62.95M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 2.00M EUR 20-F/A · filed 2022-10-26 | 326.00K EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 48.00K EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 26.01M EUR 20-F · filed 2020-03-31 |